Bruno Baillavoine


Proven Business builder, with a record of strong profitability from small Companies to Multinationals. A UK Director of Pericles Group: Leading Consulting firm, an expert in Banking and Finance with over 350 institutional clients./ Director of Cel-Sci Corporation, an NYSE Company focused on activating the immune system to fight cancer and infectious diseases. Director of an International Investor Relations Firm in Life Science and Technology./ Seating on the other UK and North American Boards.

Mr Baillavoine was Director for a US$325m Initial-UK (BET Plc). Promoted MD for the manufacturing businesses. BET’s US$3.75 billion turnarounds were the most successful turnaround of an FTSE 100.

Previously Director for the Special Operations Division of Grand Metropolitan Plc (now Diageo Plc $70 Billion Market Cap).Early career includes Director of  Prontaprint Plc; the Co grew to 100’s of locations and a successful UK float over 4 years, French and U.S. Education.

More members

Daniel Ringuet
Special Advisor
Craig Frampton
Operations Manager
David Extance
Founder & CEO
Kenneth “Buzz” West
Cluade Beauregarg
Eng, Special Advisor

Interested in joining the team?

Occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

View Careers